Electroretinography Reveals Difference in Cone Function between Syndromic and Nonsyndromic USH2A Patients

[1]  S. Tsang,et al.  Genotypic spectrum and phenotype correlations of ABCA4-associated disease in patients of south Asian descent , 2017, European Journal of Human Genetics.

[2]  Jesse D. Sengillo,et al.  Correction of Monogenic and Common Retinal Disorders with Gene Therapy , 2017, Genes.

[3]  Jesse D. Sengillo,et al.  Gene and cell‐based therapies for inherited retinal disorders: An update , 2016, American journal of medical genetics. Part C, Seminars in medical genetics.

[4]  I. Krantz,et al.  Outcomes of evaluation and testing of 660 individuals with hearing loss in a pediatric genetics of hearing loss clinic , 2016, American journal of medical genetics. Part A.

[5]  C. Klaver,et al.  Visual Prognosis in USH2A-Associated Retinitis Pigmentosa Is Worse for Patients with Usher Syndrome Type IIa Than for Those with Nonsyndromic Retinitis Pigmentosa. , 2016, Ophthalmology.

[6]  L. Hetterschijt,et al.  Antisense Oligonucleotide-based Splice Correction for USH2A-associated Retinal Degeneration Caused by a Frequent Deep-intronic Mutation. , 2016, Molecular therapy. Nucleic acids.

[7]  K. Avraham,et al.  Genetics of Hearing Loss: Syndromic. , 2015, Otolaryngologic clinics of North America.

[8]  S. Tsang,et al.  Multimodal Imaging of Central Retinal Disease Progression in a 2-Year Mean Follow-up of Retinitis Pigmentosa. , 2015, American journal of ophthalmology.

[9]  P. Mathur,et al.  Usher syndrome: Hearing loss, retinal degeneration and associated abnormalities. , 2015, Biochimica et biophysica acta.

[10]  K. Steel,et al.  A detailed clinical and molecular survey of subjects with nonsyndromic USH2A retinopathy reveals an allelic hierarchy of disease-causing variants , 2015, European Journal of Human Genetics.

[11]  Michael Bach,et al.  ISCEV Standard for full-field clinical electroretinography (2015 update) , 2014, Documenta Ophthalmologica.

[12]  E. Aller,et al.  Novel deletions involving the USH2A gene in patients with Usher syndrome and retinitis pigmentosa , 2014, Molecular vision.

[13]  J. R. Holt,et al.  Deletion of PDZD7 disrupts the Usher syndrome type 2 protein complex in cochlear hair cells and causes hearing loss in mice. , 2014, Human molecular genetics.

[14]  J. Loader,et al.  EIAV-Based Retinal Gene Therapy in the shaker1 Mouse Model for Usher Syndrome Type 1B: Development of UshStat , 2014, PloS one.

[15]  S. Tsang,et al.  Disease progression in autosomal dominant cone–rod dystrophy caused by a novel mutation (D100G) in the GUCA1A gene , 2014, Documenta Ophthalmologica.

[16]  Jennifer H. Acton,et al.  Evaluation of multimodal imaging in carriers of X-linked retinitis pigmentosa. , 2013, Experimental eye research.

[17]  N. Young,et al.  Usher Syndrome: Characteristics and Outcomes of Pediatric Cochlear Implant Recipients , 2013, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[18]  Kate E. McCaffrey,et al.  Rescue of hearing and vestibular function by antisense oligonucleotides in a mouse model of human deafness , 2013 .

[19]  M. Sokolov,et al.  Current understanding of usher syndrome type II. , 2012, Frontiers in bioscience.

[20]  Donald C Hood,et al.  Quantification of peripapillary sparing and macular involvement in Stargardt disease (STGD1). , 2011, Investigative ophthalmology & visual science.

[21]  Heidi L Rehm,et al.  Allelic hierarchy of CDH23 mutations causing non-syndromic deafness DFNB12 or Usher syndrome USH1D in compound heterozygotes , 2011, Journal of Medical Genetics.

[22]  Eberhart Zrenner,et al.  Transcorneal electrical stimulation for patients with retinitis pigmentosa: a prospective, randomized, sham-controlled exploratory study. , 2011, Investigative ophthalmology & visual science.

[23]  D. Manstein,et al.  Functional characterization of the human myosin-7a motor domain , 2011, Cellular and Molecular Life Sciences.

[24]  Yang Li,et al.  Seven novel mutations in the long isoform of the USH2A gene in Chinese families with nonsyndromic retinitis pigmentosa and Usher syndrome Type II , 2011, Molecular vision.

[25]  Susie Chang,et al.  Diagnostic Challenges in Retinitis Pigmentosa: Genotypic Multiplicity and Phenotypic Variability , 2011, Current genomics.

[26]  A. D. den Hollander,et al.  CLRN1 mutations cause nonsyndromic retinitis pigmentosa. , 2011, Ophthalmology.

[27]  A. Behrens,et al.  Riboflavin and ultraviolet light a therapy as an adjuvant treatment for medically refractive Acanthamoeba keratitis: report of 3 cases. , 2011, Ophthalmology.

[28]  E. Stone,et al.  Frequency of Usher syndrome in two pediatric populations: Implications for genetic screening of deaf and hard of hearing children , 2010, Genetics in Medicine.

[29]  T. L. McGee,et al.  Novel mutations in the long isoform of the USH2A gene in patients with Usher syndrome type II or non-syndromic retinitis pigmentosa , 2010, Journal of Medical Genetics.

[30]  G. Pazour,et al.  Ablation of Whirlin Long Isoform Disrupts the USH2 Protein Complex and Causes Vision and Hearing Loss , 2010, PLoS genetics.

[31]  Chris A. Johnson,et al.  Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A. , 2010, Archives of ophthalmology.

[32]  S. Jacobson,et al.  Mutation analysis in the long isoform of USH2A in American patients with Usher Syndrome type II , 2009, Journal of Human Genetics.

[33]  T. L. McGee,et al.  Disease course in patients with autosomal recessive retinitis pigmentosa due to the USH2A gene. , 2008, Investigative ophthalmology & visual science.

[34]  J. Sellers,et al.  Mutation spectrum of MYO7A and evaluation of a novel nonsyndromic deafness DFNB2 allele with residual function , 2008, Human mutation.

[35]  E. Berson.  Long-term visual prognoses in patients with retinitis pigmentosa: the Ludwig von Sallmann lecture. , 2007, Experimental eye research.

[36]  U. Wolfrum,et al.  Molecular basis of human Usher syndrome: deciphering the meshes of the Usher protein network provides insights into the pathomechanisms of the Usher disease. , 2006, Experimental eye research.

[37]  Aziz El-Amraoui,et al.  Usherin, the defective protein in Usher syndrome type IIA, is likely to be a component of interstereocilia ankle links in the inner ear sensory cells. , 2005, Human molecular genetics.

[38]  R. Roepman,et al.  Scaffold protein harmonin (USH1C) provides molecular links between Usher syndrome type 1 and type 2. , 2005, Human molecular genetics.

[39]  Chris A. Johnson,et al.  Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment. , 2004, Archives of ophthalmology.

[40]  C. Rivolta,et al.  Comprehensive screening of the USH2A gene in Usher syndrome type II and non-syndromic recessive retinitis pigmentosa. , 2004, Experimental eye research.

[41]  A. Swaroop,et al.  Clinical and immunohistochemical evidence for an X linked retinitis pigmentosa syndrome with recurrent infections and hearing loss in association with an RPGR mutation , 2003, Journal of medical genetics.

[42]  S. Borrego,et al.  Mutations in USH2A in Spanish patients with autosomal recessive retinitis pigmentosa: high prevalence and phenotypic variation , 2003, Journal of medical genetics.

[43]  C. Rivolta,et al.  Missense mutation in the USH2A gene: association with recessive retinitis pigmentosa without hearing loss. , 2000, American journal of human genetics.

[44]  C. Cremers,et al.  Genomic structure and identification of novel mutations in usherin, the gene responsible for Usher syndrome type IIa. , 2000, American journal of human genetics.

[45]  D. Corey,et al.  The usher syndromes. , 1999, American journal of medical genetics.

[46]  P. Sieving,et al.  Submicrovolt flicker electroretinogram: cycle-by-cycle recording of multiple harmonics with statistical estimation of measurement uncertainty. , 1998, Investigative ophthalmology & visual science.

[47]  H. Rehm,et al.  Mutation of a gene encoding a protein with extracellular matrix motifs in Usher syndrome type IIa. , 1998, Science.

[48]  D D Clowes,et al.  A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. , 1993, Archives of ophthalmology.

[49]  J. Liang,et al.  Quantitative evaluation of flicker ERG waveforms in low vision patients. , 1992, Yan ke xue bao = Eye science.

[50]  M. Sandberg,et al.  Narrow-band filtering for monitoring low-amplitude cone electroretinograms in retinitis pigmentosa. , 1988, American journal of ophthalmology.

[51]  K. Johnson.  An Update. , 1984, Journal of food protection.

[52]  J. Boughman,et al.  Usher syndrome: definition and estimate of prevalence from two high-risk populations. , 1983, Journal of chronic diseases.